SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-22-019772
Filing Date
2022-09-20
Accepted
2022-09-20 16:52:23
Documents
3
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1637
2 POA exhibit24.htm EX-24 2453036
3 POA exhibit24-1.htm EX-24.1 2453044
  Complete submission text file 0001062993-22-019772.txt   4909201
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Issuer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 TEMPLE STREET SUITE 205 NEW HAVEN CT 06510
Business Address
Farfel Gail M (Reporting) CIK: 0001614780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41429 | Film No.: 221254234